Influence of Fibroblasts on Mammary Gland Development, Breast Cancer Microenvironment Remodeling, and Cancer Cell Dissemination
暂无分享,去创建一个
L. Insabato | M. R. Ruocco | A. Arcucci | Angelica Avagliano | D. Russo | S. Masone | G. Fiume | A. Accurso | S. Montagnani | E. Vecchio | Nunzia Martucci
[1] Tamara L. Kinzer-Ursem,et al. The Dynamic Relationship of Breast Cancer Cells and Fibroblasts in Fibronectin Accumulation at Primary and Metastatic Tumor Sites , 2020, Cancers.
[2] T. Choi,et al. Roles of Autophagy in Oxidative Stress , 2020, International journal of molecular sciences.
[3] Austin E. Gillen,et al. Fibroblast subtypes define a metastatic matrisome in breast cancer. , 2020, JCI insight.
[4] A. Zannetti,et al. Recruitment of stromal cells into tumour microenvironment promote the metastatic spread of breast cancer. , 2020, Seminars in cancer biology.
[5] T. Wegman-Ostrosky,et al. Tumor microenvironment differences between primary tumor and brain metastases , 2020, Journal of Translational Medicine.
[6] D. García-Bernal,et al. Autophagy in the Immunosuppressive Perivascular Microenvironment of Glioblastoma , 2019, Cancers.
[7] Hung-Chi Cheng,et al. Fibronectin in Cancer: Friend or Foe , 2019, Cells.
[8] Michael K. Wendt,et al. Transglutaminase-2 facilitates extracellular vesicle-mediated establishment of the metastatic niche , 2019, bioRxiv.
[9] I. Meinhold-Heerlein,et al. Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials , 2019, Cancers.
[10] G. Botti,et al. Paracrine recruitment and activation of fibroblasts by c‐Myc expressing breast epithelial cells through the IGFs/IGF‐1R axis , 2019, International journal of cancer.
[11] Qian Yang,et al. Atypical ubiquitin-binding protein SHARPIN promotes breast cancer progression. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[12] M. R. Ruocco,et al. Development of a Stromal Microenvironment Experimental Model Containing Proto-Myofibroblast Like Cells and Analysis of Its Crosstalk with Melanoma Cells: A New Tool to Potentiate and Stabilize Tumor Suppressor Phenotype of Dermal Myofibroblasts , 2019, Cells.
[13] P. Hao,et al. Quantitative Phosphoproteomics Reveals System-Wide Phosphorylation Network Altered by Spry in Mouse Mammary Stromal Fibroblasts , 2019, International journal of molecular sciences.
[14] Michael K. Wendt,et al. Dynamic transition of the blood-brain barrier in the development of non-small cell lung cancer brain metastases , 2019, Oncotarget.
[15] J. Bamber,et al. Investigating the Contribution of Collagen to the Tumor Biomechanical Phenotype with Non-invasive Magnetic Resonance Elastography. , 2019, Cancer research.
[16] A. Singh,et al. Inflammation, immunosuppressive microenvironment and breast cancer: opportunities for cancer prevention and therapy. , 2019, Annals of translational medicine.
[17] J. Condeelis,et al. Tumor Microenvironment of Metastasis (TMEM) Doorways Are Restricted to the Blood Vessel Endothelium in Both Primary Breast Cancers and Their Lymph Node Metastases , 2019, Cancers.
[18] N. Erez,et al. NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis , 2019, Nature Communications.
[19] R. Sharan,et al. Evolution of metastases-associated fibroblasts in the lung microenvironment is driven by stage-specific transcriptional plasticity , 2019 .
[20] Sylvain D. Vallet,et al. Lysyl oxidases: from enzyme activity to extracellular matrix cross-links. , 2019, Essays in biochemistry.
[21] M. Pollak,et al. Metastatic Breast Carcinoma–Associated Fibroblasts Have Enhanced Protumorigenic Properties Related to Increased IGF2 Expression , 2019, Clinical Cancer Research.
[22] K. Britt,et al. The Immune Microenvironment of Breast Cancer Progression , 2019, Cancers.
[23] C. Springer,et al. 2-Aminomethylene-5-sulfonylthiazole Inhibitors of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying Tumor Growth , 2019, Journal of medicinal chemistry.
[24] E. Tajara,et al. Cellular Interactions in the Tumor Microenvironment: The Role of Secretome , 2019, Journal of Cancer.
[25] Y. Miyagi,et al. Stromal fibroblasts induce metastatic tumor cell clusters via epithelial–mesenchymal plasticity , 2019, Life Science Alliance.
[26] D. Welch,et al. Defining the Hallmarks of Metastasis. , 2019, Cancer research.
[27] J. Schneider,et al. Breast Cancer Tumor Stroma: Cellular Components, Phenotypic Heterogeneity, Intercellular Communication, Prognostic Implications and Therapeutic Opportunities , 2019, Cancers.
[28] W. Coleman. Breast Ductal Carcinoma in Situ: Precursor to Invasive Breast Cancer. , 2019, The American journal of pathology.
[29] M. R. Ruocco,et al. Mitochondrial Flexibility of Breast Cancers: A Growth Advantage and a Therapeutic Opportunity , 2019, Cells.
[30] K. Taniguchi,et al. The Sprouty/Spred family as tumor suppressors: Coming of age , 2019, Cancer science.
[31] Michael K. Wendt,et al. Spleen Tyrosine Kinase-Mediated Autophagy Is Required for Epithelial-Mesenchymal Plasticity and Metastasis in Breast Cancer. , 2019, Cancer research.
[32] E. Sonnhammer,et al. A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer , 2019, Clinical Cancer Research.
[33] Pere Roca-Cusachs,et al. Integrin Binding Dynamics Modulate Ligand-Specific Mechanosensing in Mammary Gland Fibroblasts , 2019, bioRxiv.
[34] M. Dozmorov,et al. Syndecan-1 facilitates breast cancer metastasis to the brain , 2019, bioRxiv.
[35] C. Blanpain,et al. EMT Transition States during Tumor Progression and Metastasis. , 2019, Trends in cell biology.
[36] K. Eto,et al. SHARPIN at the nexus of integrin, immune, and inflammatory signaling in human platelets , 2019, Proceedings of the National Academy of Sciences.
[37] E. White,et al. Autophagy inhibition specifically promotes epithelial-mesenchymal transition and invasion in RAS-mutated cancer cells , 2019, Autophagy.
[38] Dan Yang,et al. Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3-p38 MAPK signalling. , 2019, Cancer letters.
[39] C. Eaves,et al. Transcriptional regulation of normal human mammary cell heterogeneity and its perturbation in breast cancer , 2019, The EMBO journal.
[40] A. Mohanty,et al. Molecular mechanism of mammary gland involution: An update. , 2019, Developmental biology.
[41] J. Sumbal,et al. FGF signaling in mammary gland fibroblasts regulates multiple fibroblast functions and mammary epithelial morphogenesis , 2019, Development.
[42] Michael C. Ostrowski,et al. Stromal PTEN Regulates Extracellular Matrix Organization in the Mammary Gland , 2018, Neoplasia.
[43] A. Simon,et al. Autophagy in the renewal, differentiation and homeostasis of immune cells , 2018, Nature Reviews Immunology.
[44] Yu-qin Pan,et al. The pro-metastasis effect of circANKS1B in breast cancer , 2018, Molecular Cancer.
[45] M. Renna,et al. Revisiting Bacterial Ubiquitin Ligase Effectors: Weapons for Host Exploitation , 2018, International journal of molecular sciences.
[46] C. Yun,et al. The Roles of Autophagy in Cancer , 2018, International journal of molecular sciences.
[47] Jieqing Li,et al. Celecoxib in breast cancer prevention and therapy , 2018, Cancer management and research.
[48] A. E. del Río Hernández,et al. Role of Extracellular Matrix in Development and Cancer Progression , 2018, International journal of molecular sciences.
[49] S. K. Hemalatha,et al. Brcal Defective Breast Cancer Cells Induce in vitro Transformation of Cancer Associated Fibroblasts (CAFs) to Metastasis Associated Fibroblasts (MAF) , 2018, Scientific Reports.
[50] M. R. Ruocco,et al. Involvement of Breast Cancer-Associated Fibroblasts in Tumor Development, Therapy Resistance and Evaluation of Potential Therapeutic Strategies. , 2018, Current medicinal chemistry.
[51] Y. Liu,et al. Extracellular ATP drives breast cancer cell migration and metastasis via S100A4 production by cancer cells and fibroblasts. , 2018, Cancer letters.
[52] Michael K. Wendt,et al. Autocrine Fibronectin Inhibits Breast Cancer Metastasis , 2018, Molecular Cancer Research.
[53] M. R. Ruocco,et al. Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts , 2018, BioMed research international.
[54] E. Furth,et al. EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration. , 2018, Developmental cell.
[55] Michael K. Wendt,et al. Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancer , 2018, Breast Cancer Research.
[56] E. Turley,et al. Hyaluronan, Cancer-Associated Fibroblasts and the Tumor Microenvironment in Malignant Progression , 2018, Front. Cell Dev. Biol..
[57] F. Pouliot,et al. Exosomes Induce Fibroblast Differentiation into Cancer-Associated Fibroblasts through TGFβ Signaling , 2018, Molecular Cancer Research.
[58] A. Adamczyk,et al. Podoplanin-positive Cancer-associated Stromal Fibroblasts in Primary Tumor and Synchronous Lymph Node Metastases of HER2-overexpressing Breast Carcinomas. , 2018, Anticancer research.
[59] J. Condeelis,et al. Chemotherapy-induced metastasis: mechanisms and translational opportunities , 2018, Clinical & Experimental Metastasis.
[60] I. Amelio,et al. The hypoxic tumour microenvironment , 2018, Oncogenesis.
[61] M. Mallardo,et al. The expression of inhibitor of bruton’s tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis , 2018, Cell Death & Disease.
[62] Y. Boucher,et al. The crosstalk between breast carcinoma-associated fibroblasts and cancer cells promotes RhoA-dependent invasion via IGF-1 and PAI-1 , 2017, Oncotarget.
[63] Michael K. Wendt,et al. Inhibition of pyruvate carboxylase by 1α,25-dihydroxyvitamin D promotes oxidative stress in early breast cancer progression. , 2017, Cancer letters.
[64] R. Gray,et al. A metastasis biomarker (MetaSite Breast™ Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancer , 2017, npj Breast Cancer.
[65] A. Mohanty,et al. NEW INSIGHTS OF MAMMARY GLAND DURING DIFFERENT STAGES OF DEVELOPMENT , 2017 .
[66] Pengcheng Zhang,et al. Regulating cancer associated fibroblasts with losartan-loaded injectable peptide hydrogel to potentiate chemotherapy in inhibiting growth and lung metastasis of triple negative breast cancer. , 2017, Biomaterials.
[67] J. Sundberg,et al. Integrin beta 1 inhibition alleviates the chronic hyperproliferative dermatitis phenotype of SHARPIN-deficient mice , 2017, PloS one.
[68] Michael K. Wendt,et al. Regulation of epithelial-mesenchymal transition and metastasis by TGF-β, P-bodies, and autophagy , 2017, Oncotarget.
[69] J. Ryś,et al. Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: A possible role for cancer-associated fibroblasts in breast cancer progression , 2017, PloS one.
[70] S. Rey,et al. Hypoxic pathobiology of breast cancer metastasis. , 2017, Biochimica et biophysica acta. Reviews on cancer.
[71] M. Lewis,et al. New paradigms for the Hedgehog signaling network in mammary gland development and breast Cancer. , 2017, Biochimica et biophysica acta. Reviews on cancer.
[72] M. R. Ruocco,et al. Generation and analysis of spheroids from human primary skin myofibroblasts: an experimental system to study myofibroblasts deactivation , 2017, Cell Death Discovery.
[73] R. Hass,et al. Breast Carcinoma: From Initial Tumor Cell Detachment to Settlement at Secondary Sites , 2017, BioMed research international.
[74] D. Gourdon,et al. Breast cancer cells alter the dynamics of stromal fibronectin-collagen interactions. , 2017, Matrix biology : journal of the International Society for Matrix Biology.
[75] Jonathan J. Chen,et al. Synergistic IL-6 and IL-8 paracrine signalling pathway infers a strategy to inhibit tumour cell migration , 2017, Nature Communications.
[76] Michael C. Ostrowski,et al. Stromal PDGFR-α Activation Enhances Matrix Stiffness, Impedes Mammary Ductal Development, and Accelerates Tumor Growth , 2017, Neoplasia.
[77] Yonglei Liu,et al. Down-regulation of miR-29b in carcinoma associated fibroblasts promotes cell growth and metastasis of breast cancer , 2017, Oncotarget.
[78] X. Jiang,et al. Aberrant low expression of p85α in stromal fibroblasts promotes breast cancer cell metastasis through exosome-mediated paracrine Wnt10b , 2017, Oncogene.
[79] V. Ponomarev,et al. Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment. , 2017, International journal of oncology.
[80] J. Kzhyshkowska,et al. Intratumoral heterogeneity of macrophages and fibroblasts in breast cancer is associated with the morphological diversity of tumor cells and contributes to lymph node metastasis. , 2017, Immunobiology.
[81] Y. Xuan,et al. Tenascin C is a prognostic determinant and potential cancer-associated fibroblasts marker for breast ductal carcinoma. , 2017, Experimental and molecular pathology.
[82] P. Spellman,et al. Physiologically activated mammary fibroblasts promote postpartum mammary cancer. , 2017, JCI insight.
[83] W. Woodward,et al. Inflammatory breast cancer: a model for investigating cluster-based dissemination , 2017, bioRxiv.
[84] J. Waisman,et al. Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12 , 2017, npj Breast Cancer.
[85] Chuang Chen,et al. Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study , 2017, Oncotarget.
[86] Abigail Hielscher,et al. Fibronectin: How Its Aberrant Expression in Tumors May Improve Therapeutic Targeting , 2017, Journal of Cancer.
[87] J. Erler,et al. Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer , 2017, Oncotarget.
[88] M. Lewis,et al. The Terminal End Bud: the Little Engine that Could , 2017, Journal of Mammary Gland Biology and Neoplasia.
[89] B. Krishnamachary,et al. Breast cancer cell cyclooxygenase-2 expression alters extracellular matrix structure and function and numbers of cancer associated fibroblasts , 2017, Oncotarget.
[90] A. Mencalha,et al. NF-kappaB Is Involved in the Regulation of EMT Genes in Breast Cancer Cells , 2017, PloS one.
[91] Jun Liu,et al. Clinicopathological and prognostic significance of COX-2 immunohistochemical expression in breast cancer: a meta-analysis , 2016, Oncotarget.
[92] J. Sundberg,et al. SHARPIN regulates collagen architecture and ductal outgrowth in the developing mouse mammary gland , 2016, The EMBO journal.
[93] V. Weaver,et al. From transformation to metastasis: deconstructing the extracellular matrix in breast cancer , 2016, Cancer and Metastasis Reviews.
[94] A. Ciarrocchi,et al. Autophagy and epithelial–mesenchymal transition: an intricate interplay in cancer , 2016, Cell Death & Disease.
[95] G. Semenza,et al. Hypoxia-Inducible Factors: Master Regulators of Cancer Progression. , 2016, Trends in cancer.
[96] Pang-Kuo Lo,et al. A High-Fat Diet Promotes Mammary Gland Myofibroblast Differentiation through MicroRNA 140 Downregulation , 2016, Molecular and Cellular Biology.
[97] O. Petersen,et al. Evidence of two distinct functionally specialized fibroblast lineages in breast stroma , 2016, Breast Cancer Research.
[98] Z. Werb,et al. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer , 2016, Oncotarget.
[99] O. Klein,et al. SPRY1 regulates mammary epithelial morphogenesis by modulating EGFR-dependent stromal paracrine signaling and ECM remodeling , 2016, Proceedings of the National Academy of Sciences.
[100] M. R. Ruocco,et al. Cancer: An Oxidative Crosstalk between Solid Tumor Cells and Cancer Associated Fibroblasts , 2016, BioMed research international.
[101] C. Münz. Autophagy proteins in antigen processing for presentation on MHC molecules , 2016, Immunological reviews.
[102] J. Condeelis,et al. Signatures of breast cancer metastasis at a glance , 2016, Journal of Cell Science.
[103] H. Kiaris,et al. A CCL8 gradient drives breast cancer cell dissemination , 2016, Oncogene.
[104] F. Gu,et al. Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications , 2016, Frontiers of Medicine.
[105] J. Frost,et al. Minireview: Mouse Models of Rho GTPase Function in Mammary Gland Development, Tumorigenesis, and Metastasis. , 2016, Molecular endocrinology.
[106] T. Oskarsson,et al. The extracellular matrix in breast cancer. , 2016, Advanced drug delivery reviews.
[107] R. Buchsbaum,et al. The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis , 2016, Breast Cancer Research.
[108] R. Buchsbaum,et al. Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go , 2016, Cancers.
[109] S. Gerecht,et al. Fibronectin Deposition Participates in Extracellular Matrix Assembly and Vascular Morphogenesis , 2016, PloS one.
[110] J. Erler,et al. Lysyl Oxidase, a Targetable Secreted Molecule Involved in Cancer Metastasis. , 2016, Cancer research.
[111] R. Datar,et al. Identification of Cancer-Associated Fibroblasts in Circulating Blood from Patients with Metastatic Breast Cancer. , 2015, Cancer research.
[112] Chang S. Chan,et al. Autophagy, Metabolism, and Cancer , 2015, Clinical Cancer Research.
[113] Catherine C. Park,et al. Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. , 2015, Integrative biology : quantitative biosciences from nano to macro.
[114] C. Lovly,et al. Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway Blockade , 2015, Clinical Cancer Research.
[115] Yarong Wang,et al. Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage-Derived VEGFA. , 2015, Cancer discovery.
[116] A. Hjerpe,et al. Syndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and Prognostication , 2015, Disease markers.
[117] Bo Ri Seo,et al. Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis , 2015, Science Translational Medicine.
[118] Bonnie F. Sloane,et al. Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration , 2015, BMC Cancer.
[119] Shukun Tang,et al. Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling , 2015, Cell Death and Differentiation.
[120] G. Bauerschmitz,et al. Inhibition of SDF-1/CXCR4-induced epithelial–mesenchymal transition by kisspeptin-10 , 2015, Breast Cancer Research and Treatment.
[121] D. Radisky,et al. Matrix metalloproteinases as breast cancer drivers and therapeutic targets. , 2015, Frontiers in bioscience.
[122] R. Linding,et al. The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase , 2015, Nature.
[123] Xinbing Sui,et al. The role of STAT3 in autophagy , 2015, Autophagy.
[124] G. Cuda,et al. CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation , 2015, The Journal of Biological Chemistry.
[125] Seamus J. Martin,et al. Autophagy in malignant transformation and cancer progression , 2015, The EMBO journal.
[126] Zong-fang Li,et al. GPER in CAFs regulates hypoxia-driven breast cancer invasion in a CTGF-dependent manner. , 2015, Oncology reports.
[127] M. Bissell,et al. Mammary gland development: cell fate specification, stem cells and the microenvironment , 2015, Development.
[128] Michael D. Brooks,et al. Epithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistance. , 2015, Current pharmaceutical design.
[129] H. van Dam,et al. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models , 2015, Breast Cancer Research.
[130] Joan G. Jones,et al. TMEM: a novel breast cancer dissemination marker for the assessment of metastatic risk. , 2015, Biomarkers in medicine.
[131] J. Makki,et al. Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance , 2015, Clinical medicine insights. Pathology.
[132] Byoungduck Park,et al. Baohuoside I suppresses invasion of cervical and breast cancer cells through the downregulation of CXCR4 chemokine receptor expression. , 2014, Biochemistry.
[133] Gretchen L. Gierach,et al. Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology. , 2014, Journal of the National Cancer Institute.
[134] Kelvin K. Tsai,et al. Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression , 2014, Breast Cancer Research.
[135] C. Bancone,et al. Analysis of Extracellular Superoxide Dismutase and Akt in Ascending Aortic Aneurysm With Tricuspid or Bicuspid Aortic Valve , 2014, European journal of histochemistry : EJH.
[136] Robin L. Anderson,et al. Stromal Fibroblasts and the Immune Microenvironment: Partners in Mammary Gland Biology and Pathology? , 2014, Journal of Mammary Gland Biology and Neoplasia.
[137] Pengfei Lu,et al. Modulation of Fibroblast Growth Factor Signaling Is Essential for Mammary Epithelial Morphogenesis , 2014, PloS one.
[138] E. Cukierman,et al. The wound healing, chronic fibrosis, and cancer progression triad. , 2014, Physiological genomics.
[139] F. Vizoso,et al. Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis , 2014, Histopathology.
[140] Z. Wang,et al. Antitumour activity of the recombination polypeptide GST-NT21MP is mediated by inhibition of CXCR4 pathway in breast cancer , 2014, British journal of cancer.
[141] Yu-mei Feng,et al. Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling , 2013, British Journal of Cancer.
[142] N. Hogg,et al. SHARPIN regulates uropod detachment in migrating lymphocytes. , 2013, Cell reports.
[143] Jing Yang,et al. Epithelial–mesenchymal plasticity in carcinoma metastasis , 2013, Genes & development.
[144] S. Qiu,et al. Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells , 2013, Autophagy.
[145] M. Maggiolini,et al. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs) , 2013, Breast Cancer Research.
[146] R. S. Johnson,et al. Tumour oxygenation: implications for breast cancer prognosis , 2013, Journal of internal medicine.
[147] R. Lonser,et al. Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms. , 2013, Journal of neurosurgery.
[148] A. Rossi,et al. Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-κB , 2013, PloS one.
[149] Michael K. Wendt,et al. Epithelial to Mesenchymal Transition Promotes Breast Cancer Progression via a Fibronectin-dependent STAT3 Signaling Pathway* , 2013, The Journal of Biological Chemistry.
[150] Han-Sung Jung,et al. Pleiotropic Functions of Fibroblast Growth Factor Signaling in Embryonic Mammary Gland Development , 2013, Journal of Mammary Gland Biology and Neoplasia.
[151] D. Fletcher,et al. Patterned Collagen Fibers Orient Branching Mammary Epithelium through Distinct Signaling Modules , 2013, Current Biology.
[152] T. Tan,et al. Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis. , 2013, Cancer research.
[153] M. R. Ruocco,et al. Markers of mitochondrial dysfunction during the diclofenac-induced apoptosis in melanoma cell lines. , 2013, Biochimie.
[154] K. Francis,et al. Enhanced detection of myeloperoxidase activity in deep tissues through luminescent excitation of near-infrared nanoparticles , 2013, Nature Medicine.
[155] B. Parvin,et al. Breast fibroblasts modulate early dissemination, tumorigenesis, and metastasis through alteration of extracellular matrix characteristics. , 2013, Neoplasia.
[156] Fei Zhang,et al. Aquaporin3 Is Required for FGF-2-Induced Migration of Human Breast Cancers , 2013, PloS one.
[157] S. Hilsenbeck,et al. Fibroblast Growth Factor Receptor Signaling Is Essential for Normal Mammary Gland Development and Stem Cell Function , 2013, Stem cells.
[158] F. Rösel,et al. Mammary fibroblasts regulate morphogenesis of normal and tumorigenic breast epithelial cells by mechanical and paracrine signals. , 2012, Cancer letters.
[159] J. Wrana,et al. Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration , 2012, Cell.
[160] L. Galluzzi,et al. Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity. , 2012, Molecular cell.
[161] C. Gialeli,et al. Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid. , 2012, Biochimica et biophysica acta.
[162] Yanqiu Zhao,et al. TISSUE-SPECIFIC STEM CELLS Inhibition of TGF-b/Smad Signaling by BAMBI Blocks Differentiation of Human Mesenchymal Stem Cells to Carcinoma-Associated Fibroblasts and Abolishes Their Protumor Effects , 2012 .
[163] Meiyappan Solaiyappan,et al. Collagen I fiber density increases in lymph node positive breast cancers: pilot study , 2012, Journal of biomedical optics.
[164] P. Scherer,et al. Adipocyte-derived endotrophin promotes malignant tumor progression. , 2012, The Journal of clinical investigation.
[165] M. Detmar,et al. Interaction of tumor cells and lymphatic vessels in cancer progression , 2012, Oncogene.
[166] R. Jain,et al. TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma , 2012, Proceedings of the National Academy of Sciences.
[167] Y. DeClerck. Desmoplasia: a response or a niche? , 2012, Cancer discovery.
[168] H. Oh,et al. STAT3 Protein Interacts with Class O Forkhead Transcription Factors in the Cytoplasm and Regulates Nuclear/Cytoplasmic Localization of FoxO1 and FoxO3a Proteins in CD4+ T Cells* , 2012, The Journal of Biological Chemistry.
[169] C. Andl,et al. The regulation of cell-cell adhesion during epithelial-mesenchymal transition, motility and tumor progression , 2012, Cell adhesion & migration.
[170] L. Hinck,et al. Mammary gland development , 2012, Wiley interdisciplinary reviews. Developmental biology.
[171] J. Sleeman. The metastatic niche and stromal progression , 2012, Cancer and Metastasis Reviews.
[172] P. Carmeliet,et al. SnapShot: Tumor Angiogenesis , 2012, Cell.
[173] N. Cho,et al. Invasive breast cancer induces laminin-332 upregulation and integrin β4 neoexpression in myofibroblasts to confer an anoikis-resistant phenotype during tissue remodeling , 2012, Breast Cancer Research.
[174] W. Ye,et al. CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells. , 2012, Cancer research.
[175] Joo H. Kang,et al. Inhibition of mammary tumor growth using lysyl oxidase-targeting nanoparticles to modify extracellular matrix. , 2012, Nano letters.
[176] Matthew W. Conklin,et al. Why the stroma matters in breast cancer , 2012, Cell adhesion & migration.
[177] D. Newgreen,et al. Contribution of Fibroblast and Mast Cell (Afferent) and Tumor (Efferent) IL-6 Effects within the Tumor Microenvironment , 2012, Cancer Microenvironment.
[178] Z. Werb,et al. The extracellular matrix: A dynamic niche in cancer progression , 2012, The Journal of cell biology.
[179] O. Kallioniemi,et al. SHARPIN is an endogenous inhibitor of β1-integrin activation , 2011, Nature Cell Biology.
[180] M. R. Ruocco,et al. Analysis of extracellular superoxide dismutase in fibroblasts from patients with systemic sclerosis. , 2011, Journal of biological regulators and homeostatic agents.
[181] N. Frangogiannis,et al. TGF-β signaling in fibrosis , 2011, Growth factors.
[182] F. Kraeber-Bodéré,et al. Syndecan-1 Antigen, a Promising New Target for Triple-negative Breast Cancer Immuno-pet and Radioimmunotherapy. a Preclinical Study on Mda-mb-468 Xenograft Tumors , 2022 .
[183] Scott E. Kern,et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis , 2011, Nature.
[184] Y. Eishi,et al. Autophagy-deficient mice develop multiple liver tumors. , 2011, Genes & development.
[185] David Beebe,et al. Syndecan-1 in breast cancer stroma fibroblasts regulates extracellular matrix fiber organization and carcinoma cell motility. , 2011, The American journal of pathology.
[186] F. Pépin,et al. Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes , 2011, Oncogene.
[187] Paolo P. Provenzano,et al. Aligned Collagen Is a Prognostic Signature for Survival in Human Breast Carcinoma Address Reprint Requests to See Related Commentary on Page 966 , 2022 .
[188] J. Cheng,et al. Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signalling , 2011, Nature.
[189] F. Sotgia,et al. Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment , 2011, Cancer biology & therapy.
[190] R. Jain,et al. Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors , 2011, Proceedings of the National Academy of Sciences.
[191] D. Radisky,et al. Microenvironmental Influences that Drive Progression from Benign Breast Disease to Invasive Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.
[192] G. Sethi,et al. Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells. , 2010, Biochemical pharmacology.
[193] J. Condeelis,et al. Metastasis: tumor cells becoming MENAcing. , 2010, Trends in cell biology.
[194] Kornelia Polyak,et al. The role of the microenvironment in mammary gland development and cancer. , 2010, Cold Spring Harbor perspectives in biology.
[195] Robert A. Weinberg,et al. Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts , 2010, Proceedings of the National Academy of Sciences.
[196] F. Schmitt,et al. Angiogenesis and Breast Cancer , 2010, Journal of oncology.
[197] Mikala Egeblad,et al. Dynamic interplay between the collagen scaffold and tumor evolution. , 2010, Current opinion in cell biology.
[198] Erin J. McCave,et al. The Normal Microenvironment Directs Mammary Gland Development , 2010, Journal of Mammary Gland Biology and Neoplasia.
[199] Z. Werb,et al. Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.
[200] A. Tsirigos,et al. Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: Similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling" , 2010, Aging.
[201] A. Purushothaman,et al. Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis. , 2010, Blood.
[202] Akira Oshima,et al. Transient Tumor-Fibroblast Interactions Increase Tumor Cell Malignancy by a TGF-β Mediated Mechanism in a Mouse Xenograft Model of Breast Cancer , 2010, PloS one.
[203] D. Ribatti,et al. Targeting tumor lymphangiogenesis: an update. , 2010, Current medicinal chemistry.
[204] Bonnie F. Sloane,et al. Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ. , 2009, Cancer research.
[205] Mikala Egeblad,et al. Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.
[206] Metin N. Gurcan,et al. Pten in Stromal Fibroblasts Suppresses Mammary Epithelial Tumors , 2009, Nature.
[207] C. Brinckerhoff,et al. CXCR4 and Matrix Metalloproteinase-1 Are Elevated in Breast Carcinoma–Associated Fibroblasts and in Normal Mammary Fibroblasts Exposed to Factors Secreted by Breast Cancer Cells , 2009, Molecular Cancer Research.
[208] Raghu Kalluri,et al. EMT: when epithelial cells decide to become mesenchymal-like cells. , 2009, The Journal of clinical investigation.
[209] J. Pringle,et al. Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms , 2009, Breast Cancer Research.
[210] Bethan Psaila,et al. The metastatic niche: adapting the foreign soil , 2009, Nature Reviews Cancer.
[211] K. Polyak,et al. Role of COX-2 in epithelial–stromal cell interactions and progression of ductal carcinoma in situ of the breast , 2009, Proceedings of the National Academy of Sciences.
[212] F. Vizoso,et al. Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumor stromal fibroblasts and those at the invasive front of breast carcinomas , 2009, Breast Cancer Research and Treatment.
[213] Gerhard Christofori,et al. EMT, the cytoskeleton, and cancer cell invasion , 2009, Cancer and Metastasis Reviews.
[214] A. Molinolo,et al. Carcinoma‐associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF‐2/FGFR‐2 axis , 2008, International journal of cancer.
[215] F. Portillo,et al. Transcriptional regulation of cell polarity in EMT and cancer , 2008, Oncogene.
[216] T. Rosol,et al. Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. , 2008, Cancer Research.
[217] Z. Werb,et al. Genetic mosaic analysis reveals FGF receptor 2 function in terminal end buds during mammary gland branching morphogenesis. , 2008, Developmental biology.
[218] Karen Plaut,et al. Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-β1) increase invasion rate of tumor cells: a population study , 2008, Breast Cancer Research and Treatment.
[219] R. Stupp,et al. Tenascin‐W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients , 2008, International journal of cancer.
[220] Johanna Andrae,et al. Role of platelet-derived growth factors in physiology and medicine. , 2008, Genes & development.
[221] N. Karamanos,et al. Imatinib Mesylate Inhibits Proliferation and Exerts an Antifibrotic Effect in Human Breast Stroma Fibroblasts , 2008, Molecular Cancer Research.
[222] C. Rueden,et al. Bmc Medicine Collagen Density Promotes Mammary Tumor Initiation and Progression , 2022 .
[223] Andrew J Ewald,et al. Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. , 2008, Developmental cell.
[224] C. Watson,et al. Mammary development in the embryo and adult: a journey of morphogenesis and commitment , 2008, Development.
[225] R. Eils,et al. Systemic spread is an early step in breast cancer. , 2008, Cancer cell.
[226] Hyunsuk Shim,et al. Discovery of small molecule CXCR4 antagonists. , 2007, Journal of medicinal chemistry.
[227] R. Walker,et al. Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion , 2007, Breast Cancer Research.
[228] C. Ruiz,et al. Tenascin-W is a novel marker for activated tumor stroma in low-grade human breast cancer and influences cell behavior. , 2007, Cancer research.
[229] Paula D. Bos,et al. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis , 2007, Nature.
[230] Crispin J. Miller,et al. Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers. , 2007, Cancer research.
[231] D. Newgreen,et al. Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factors , 2007, Breast Cancer Research.
[232] Paolo P. Provenzano,et al. Collagen reorganization at the tumor-stromal interface facilitates local invasion , 2006, BMC medicine.
[233] J. Pollard,et al. Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.
[234] Romayne A. Thompson,et al. Age-related lobular involution and risk of breast cancer. , 2006, Journal of the National Cancer Institute.
[235] J. Erler,et al. Lysyl oxidase mediates hypoxic control of metastasis. , 2006, Cancer research.
[236] Z. Werb,et al. Hormonal and local control of mammary branching morphogenesis. , 2006, Differentiation; research in biological diversity.
[237] B. Alicke,et al. The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models , 2006, Molecular Cancer Therapeutics.
[238] A. Friedl,et al. Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis , 2006, Oncogene.
[239] P. Chambon,et al. Paracrine signaling through the epithelial estrogen receptor α is required for proliferation and morphogenesis in the mammary gland , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[240] Jeannette Bigler,et al. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics , 2006, Nature Reviews Cancer.
[241] Jeffrey M. Rosen,et al. Pleiotropic effects of FGFR1 on cell proliferation, survival, and migration in a 3D mammary epithelial cell model , 2005, The Journal of cell biology.
[242] E. van Marck,et al. Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer , 2005, British Journal of Cancer.
[243] R. Sormunen,et al. Lysyl oxidase is essential for normal development and function of the respiratory system and for the integrity of elastic and collagen fibers in various tissues. , 2005, The American journal of pathology.
[244] M. Lishner,et al. Non‐steroidal anti‐inflammatory drugs for the prevention and treatment of cancer , 2005, Journal of internal medicine.
[245] J. Peterse,et al. Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.
[246] Dennis C. Sgroi,et al. Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.
[247] E. Petricoin,et al. Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. , 2005, The Journal of clinical investigation.
[248] P. Bonnier,et al. Overexpression of hypoxia‐inducible factor HIF‐1α predicts early relapse in breast cancer: Retrospective study in a series of 745 patients , 2005, International journal of cancer.
[249] P. Schedin,et al. Mammary ECM composition and function are altered by reproductive state , 2004, Molecular carcinogenesis.
[250] D. Piwnica-Worms,et al. CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer , 2004, Cancer Research.
[251] Jose Russo,et al. Development of the human breast. , 2004, Maturitas.
[252] S. Nie,et al. Inhibition of Breast Cancer Metastasis by Selective Synthetic Polypeptide against CXCR4 , 2004, Cancer Research.
[253] Ruud H. Brakenhoff,et al. Dissecting the metastatic cascade , 2004, Nature Reviews Cancer.
[254] R. Weinberg,et al. Reconstruction of functionally normal and malignant human breast tissues in mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[255] P. Goss,et al. The role of COX-2 inhibition in breast cancer treatment and prevention. , 2004, Seminars in oncology.
[256] Takako Sasaki,et al. Laminin: the crux of basement membrane assembly. , 2004, The Journal of cell biology.
[257] A. Otaka,et al. T140 analogs as CXCR4 antagonists identified as anti‐metastatic agents in the treatment of breast cancer , 2003, FEBS letters.
[258] Peter Friedl,et al. Compensation mechanism in tumor cell migration , 2003, The Journal of cell biology.
[259] G. Tuszynski,et al. Fibroblasts promote breast cancer cell invasion by upregulating tumor matrix metalloproteinase-9 production. , 2002, Surgery.
[260] Kazuki Nabeshima,et al. Matrix metalloproteinases in tumor invasion: Role for cell migration , 2002, Pathology international.
[261] M. V. van Oers,et al. Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma. , 2002, Blood.
[262] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[263] B. Hinz,et al. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. , 2001, Molecular biology of the cell.
[264] E. Howard,et al. Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast. , 2000, Experimental cell research.
[265] K. Seibert,et al. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. , 2000, Cancer research.
[266] H. Hibshoosh,et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1 , 1999, Nature.
[267] M. J. Stanley,et al. Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma. , 1999, American journal of clinical pathology.
[268] R. Weinberg,et al. A paracrine role for the epithelial progesterone receptor in mammary gland development. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[269] L. Orci,et al. Roles of Hepatocyte Growth Factor/Scatter Factor and Transforming Growth Factor-β1 in Mammary Gland Ductal Morphogenesis , 1998, Journal of Mammary Gland Biology and Neoplasia.
[270] G. Stamp,et al. Fibroblast growth factor receptor signalling has a role in lobuloalveolar development of the mammary gland. , 1997, Journal of cell science.
[271] C. Larabell,et al. Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies , 1997, The Journal of cell biology.
[272] G. Colditz,et al. Prospective study of regular aspirin use and the risk of breast cancer. , 1996, Journal of the National Cancer Institute.
[273] V. Nguyen,et al. Occult deposition of eosinophil peroxidase in a subset of human breast carcinomas. , 1996, The American journal of pathology.
[274] M. Bissell,et al. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. , 1995, The Journal of clinical investigation.
[275] R. Tarone,et al. On the possible role of involution in the natural history of breast cancer , 1993 .
[276] Z. Werb,et al. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution , 1992, The Journal of cell biology.
[277] W. Schürch,et al. Smooth‐muscle differentiation in stromal cells of malignant and non‐malignant breast tissues , 1988, International journal of cancer.
[278] A Ahmed,et al. Stromal changes in invasive breast carcinoma: An ultrastructural study , 1987, The Journal of pathology.
[279] C C Bird,et al. Morphometric studies of age related changes in normal human breast and their significance for evolution of mammary cancer. , 1985, Journal of clinical pathology.
[280] H. Bern,et al. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. , 1959, Cancer research.
[281] Zuzana Koledova,et al. 3D Coculture of Mammary Organoids with Fibrospheres: A Model for Studying Epithelial-Stromal Interactions During Mammary Branching Morphogenesis. , 2017, Methods in molecular biology.
[282] Jihe Zhao,et al. The Role of chemokine receptor CXCR4 in breast cancer metastasis. , 2013, American journal of cancer research.
[283] Suyun Huang,et al. Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice , 2004, Clinical & Experimental Metastasis.
[284] E. Lander,et al. A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.
[285] M. Götte,et al. Functions of cell surface heparan sulfate proteoglycans. , 1999, Annual review of biochemistry.